TheraCyte · Our Technology
Cell encapsulation designed for immunoisolation and vascularization.
A membrane-based system developed to support transplanted cells while helping protect them from immune rejection.
How the TheraCyte System Works
The TheraCyte™ system for encapsulating and transplanting cells uses a thin, membrane-based polymeric chamber fabricated from biocompatible membranes. Its design combines immunoisolation with the development of capillaries near the implanted device.
The System
Protection and exchange, working together.
The chamber’s biocompatible membranes are designed to protect enclosed allogeneic cells from rejection by the recipient.
When implanted beneath the skin, the system encourages blood capillaries to develop close to the membrane surfaces. This surrounding vascularization helps nourish the encapsulated tissue, supports communication with the host, and aids uptake of molecules produced by the implanted cells.
Immunoisolation
Biocompatible membranes provide a protective barrier around encapsulated allogeneic cells.
Vascularization
Subcutaneous implantation promotes nearby capillary growth to help supply the encapsulated tissue.
Molecular Exchange
The system supports transport of oxygen, nutrients, and therapeutic molecules across the membranes.
Explore the technology in research.
Review published studies, examine the TheraCyte System, or contact the team about research applications. Devices currently offered are for research purposes.